# Southern Co: financial statements, quarterly

SO · NYSE · CIK 92122 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/so.md) · [Financials](/companies/so/financials.md) · [Filings](/companies/so/filings.md) · [Insiders](/companies/so/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/so/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5,748](/filings/0000092122-24-000075.md) | [6,980](/filings/0000092122-24-000089.md) | [6,045 d](/filings/0000092122-26-000006.md) | [6,646](/filings/0000092122-25-000042.md) | [6,463](/filings/0000092122-25-000076.md) | [7,274](/filings/0000092122-25-000084.md) | [6,341 d](/filings/0000092122-26-000006.md) | [7,775](/filings/0000092122-26-000034.md) | [6,973](/filings/0000092122-25-000076.md) | [7,823](/filings/0000092122-25-000084.md) | [6,981 d](/filings/0000092122-26-000006.md) | [8,397](/filings/0000092122-26-000034.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [1,290](/filings/0000092122-24-000075.md) | [2,110](/filings/0000092122-24-000089.md) | [1,207 d](/filings/0000092122-26-000006.md) | [1,703](/filings/0000092122-25-000042.md) | [1,939](/filings/0000092122-25-000076.md) | [2,368](/filings/0000092122-25-000084.md) | [1,058 d](/filings/0000092122-26-000006.md) | [2,010](/filings/0000092122-26-000034.md) | [1,764](/filings/0000092122-25-000076.md) | [2,594](/filings/0000092122-25-000084.md) | [917 d](/filings/0000092122-26-000006.md) | [2,018](/filings/0000092122-26-000034.md) |
| Income tax | $m | [98.0](/filings/0000092122-24-000075.md) | [297](/filings/0000092122-24-000089.md) | [4.0 d](/filings/0000092122-26-000006.md) | [223](/filings/0000092122-25-000042.md) | [290](/filings/0000092122-25-000076.md) | [377](/filings/0000092122-25-000084.md) | [79.0 d](/filings/0000092122-26-000006.md) | [280](/filings/0000092122-26-000034.md) | [289](/filings/0000092122-25-000076.md) | [404](/filings/0000092122-25-000084.md) | [(145) d](/filings/0000092122-26-000006.md) | [228](/filings/0000092122-26-000034.md) |
| Net income | $m | [823](/filings/0000092122-24-000075.md) | [1,432](/filings/0000092122-24-000089.md) | [923 d](/filings/0000092122-26-000006.md) | [1,071](/filings/0000092122-25-000084.md) | [1,203](/filings/0000092122-25-000076.md) | [1,535](/filings/0000092122-25-000084.md) | [534 d](/filings/0000092122-26-000006.md) | [1,334](/filings/0000092122-26-000034.md) | [880](/filings/0000092122-25-000076.md) | [1,711](/filings/0000092122-25-000084.md) | [416 d](/filings/0000092122-26-000006.md) | [1,356](/filings/0000092122-26-000034.md) |
| Diluted EPS | $ per share | [0.76](/filings/0000092122-24-000075.md) | [1.29](/filings/0000092122-24-000089.md) | not reported | [1.03](/filings/0000092122-25-000042.md) | [1.09](/filings/0000092122-25-000076.md) | [1.39](/filings/0000092122-25-000084.md) | not reported | [1.21](/filings/0000092122-26-000034.md) | [0.79](/filings/0000092122-25-000076.md) | [1.54](/filings/0000092122-25-000084.md) | not reported | [1.20](/filings/0000092122-26-000034.md) |
| Basic EPS | $ per share | [0.77](/filings/0000092122-24-000075.md) | [1.30](/filings/0000092122-24-000089.md) | not reported | [1.03](/filings/0000092122-25-000042.md) | [1.10](/filings/0000092122-25-000076.md) | [1.40](/filings/0000092122-25-000084.md) | not reported | [1.21](/filings/0000092122-26-000034.md) | [0.80](/filings/0000092122-25-000076.md) | [1.55](/filings/0000092122-25-000084.md) | not reported | [1.21](/filings/0000092122-26-000034.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [2.1](/filings/0000092122-23-000070.md) | [1.7](/filings/0000092122-23-000101.md) | [0.7](/filings/0000092122-25-000018.md) | [0.7](/filings/0000092122-24-000042.md) | [1.2](/filings/0000092122-24-000075.md) | [1.0](/filings/0000092122-24-000089.md) | [1.1](/filings/0000092122-26-000006.md) | [2.3](/filings/0000092122-25-000042.md) | [1.3](/filings/0000092122-25-000076.md) | [3.3](/filings/0000092122-25-000084.md) | [1.6](/filings/0000092122-26-000034.md) | [1.0](/filings/0000092122-26-000034.md) |
| Current assets | $bn | [11.0](/filings/0000092122-23-000070.md) | [11.1](/filings/0000092122-23-000101.md) | [10.4](/filings/0000092122-25-000018.md) | [10.5](/filings/0000092122-24-000042.md) | [11.0](/filings/0000092122-24-000075.md) | [11.0](/filings/0000092122-24-000089.md) | [10.7](/filings/0000092122-26-000006.md) | [11.8](/filings/0000092122-25-000042.md) | [10.8](/filings/0000092122-25-000076.md) | [12.6](/filings/0000092122-25-000084.md) | [10.9](/filings/0000092122-26-000034.md) | [10.0](/filings/0000092122-26-000034.md) |
| Total assets | $bn | [137](/filings/0000092122-23-000070.md) | [138](/filings/0000092122-23-000101.md) | [139](/filings/0000092122-26-000006.md) | [140](/filings/0000092122-24-000042.md) | [142](/filings/0000092122-24-000075.md) | [144](/filings/0000092122-24-000089.md) | [145](/filings/0000092122-26-000006.md) | [148](/filings/0000092122-25-000042.md) | [149](/filings/0000092122-25-000076.md) | [153](/filings/0000092122-25-000084.md) | [156](/filings/0000092122-26-000034.md) | [157](/filings/0000092122-26-000034.md) |
| Current liabilities | $bn | [13.2](/filings/0000092122-23-000070.md) | [13.2](/filings/0000092122-23-000101.md) | [13.5](/filings/0000092122-25-000018.md) | [11.5](/filings/0000092122-24-000042.md) | [12.0](/filings/0000092122-24-000075.md) | [12.2](/filings/0000092122-24-000089.md) | [16.0](/filings/0000092122-26-000006.md) | [13.8](/filings/0000092122-25-000042.md) | [14.6](/filings/0000092122-25-000076.md) | [16.7](/filings/0000092122-25-000084.md) | [16.9](/filings/0000092122-26-000034.md) | [15.3](/filings/0000092122-26-000034.md) |
| Total liabilities | $bn | [102](/filings/0000092122-23-000070.md) | [103](/filings/0000092122-23-000101.md) | [104](/filings/0000092122-25-000018.md) | [105](/filings/0000092122-24-000042.md) | [106](/filings/0000092122-24-000075.md) | [107](/filings/0000092122-24-000089.md) | [109](/filings/0000092122-26-000006.md) | [111](/filings/0000092122-25-000042.md) | [112](/filings/0000092122-25-000076.md) | [115](/filings/0000092122-25-000084.md) | [117](/filings/0000092122-26-000034.md) | [117](/filings/0000092122-26-000034.md) |
| Short-term borrowings | $bn | [1.6](/filings/0000092122-23-000070.md) | [1.7](/filings/0000092122-23-000101.md) | [2.3](/filings/0000092122-25-000018.md) | [2.4](/filings/0000092122-24-000042.md) | [1.3](/filings/0000092122-24-000075.md) | [0.7](/filings/0000092122-24-000089.md) | [1.3](/filings/0000092122-26-000006.md) | [0.5](/filings/0000092122-25-000042.md) | [1.0](/filings/0000092122-25-000076.md) | [0.1](/filings/0000092122-25-000084.md) | [0.7](/filings/0000092122-26-000034.md) | [1.7](/filings/0000092122-26-000034.md) |
| Shareholders' equity | $bn | [34.6](/filings/0000092122-24-000089.md) | [35.3](/filings/0000092122-24-000089.md) | [31.4](/filings/0000092122-25-000018.md) | [35.6](/filings/0000092122-25-000084.md) | [36.1](/filings/0000092122-25-000084.md) | [36.9](/filings/0000092122-25-000084.md) | [33.2](/filings/0000092122-26-000006.md) | [37.2](/filings/0000092122-26-000034.md) | [37.3](/filings/0000092122-25-000084.md) | [38.3](/filings/0000092122-25-000084.md) | [36.0](/filings/0000092122-26-000006.md) | [39.9](/filings/0000092122-26-000034.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [2,056 d](/filings/0000092122-24-000075.md) | [2,840 d](/filings/0000092122-24-000089.md) | [1,813 d](/filings/0000092122-26-000006.md) | [1,311](/filings/0000092122-25-000042.md) | [2,688 d](/filings/0000092122-25-000076.md) | [3,616 d](/filings/0000092122-25-000084.md) | [2,173 d](/filings/0000092122-26-000006.md) | [1,250](/filings/0000092122-26-000034.md) | [2,181 d](/filings/0000092122-25-000076.md) | [3,774 d](/filings/0000092122-25-000084.md) | [2,597 d](/filings/0000092122-26-000006.md) | [1,226](/filings/0000092122-26-000034.md) |
| Capital expenditure | $m | [2,048 d](/filings/0000092122-24-000075.md) | [2,663 d](/filings/0000092122-24-000089.md) | [2,534 d](/filings/0000092122-26-000006.md) | [1,770](/filings/0000092122-25-000042.md) | [2,125 d](/filings/0000092122-25-000076.md) | [2,311 d](/filings/0000092122-25-000084.md) | [2,749 d](/filings/0000092122-26-000006.md) | [2,437](/filings/0000092122-26-000034.md) | [2,800 d](/filings/0000092122-25-000076.md) | [3,215 d](/filings/0000092122-25-000084.md) | [4,285 d](/filings/0000092122-26-000006.md) | [2,944](/filings/0000092122-26-000034.md) |
| Dividends paid | $m | [764 d](/filings/0000092122-24-000075.md) | [765 d](/filings/0000092122-24-000089.md) | [764 d](/filings/0000092122-26-000006.md) | [733](/filings/0000092122-25-000042.md) | [754 d](/filings/0000092122-25-000076.md) | [733 d](/filings/0000092122-25-000084.md) | [734 d](/filings/0000092122-26-000006.md) | [736](/filings/0000092122-26-000034.md) | [758 d](/filings/0000092122-25-000076.md) | [760 d](/filings/0000092122-25-000084.md) | [761 d](/filings/0000092122-26-000006.md) | [776](/filings/0000092122-26-000034.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [1,072](/filings/0000092122-23-000070.md) | [1,088](/filings/0000092122-23-000101.md) | [1,098](/filings/0000092122-24-000042.md) | [1,098](/filings/0000092122-24-000075.md) | [1,099](/filings/0000092122-24-000089.md) | [1,100](/filings/0000092122-25-000042.md) | [1,102](/filings/0000092122-25-000076.md) | [1,103](/filings/0000092122-25-000084.md) | [1,105](/filings/0000092122-26-000034.md) | [1,108](/filings/0000092122-25-000076.md) | [1,110](/filings/0000092122-25-000084.md) | [1,128](/filings/0000092122-26-000034.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,127,301,098 at 2026-03-31, from the cover of the [10-Q filed 2026-04-30](/filings/0000092122-26-000034.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:20 ET. No prices; not investment advice.